This bill, titled the Fair Prices for Local Businesses Act, amends the Clayton Act to broaden the federal prohibition against price discrimination. It expands the law's scope to cover products and services rather than just physical goods, and extends its reach to include activities that affect commerce beyond direct commercial transactions. The bill also clarifies definitions of purchasing and adds liability for entities that induce or benefit from price discrimination, while providing a higher sales threshold for smaller businesses. Additionally, it strengthens legal remedies for victims of price discrimination by establishing a presumption of injury and allowing for additional damages beyond the amount of the discrimination itself.
This bill, known as the Local Data for Better Conservation Act, would require the federal government to use data collected by states when deciding whether to list or remove species from the endangered or threatened lists. The key provision adds a new requirement to the Endangered Species Act mandating that the Secretary of the Interior must accept and integrate state-collected information into listing determinations. This change directly affects state agencies that gather biological and environmental data, as well as federal wildlife officials who make conservation decisions. The bill aims to incorporate local knowledge and regional expertise into federal conservation assessments without altering the overall framework of the Endangered Species Act.
This bill requires all states to submit detailed data on Supplemental Nutrition Assistance Program (SNAP) fraud to the Department of Agriculture. The data must include information on fraud cases, enforcement actions, recoveries, and specific instances involving deceased individuals or false social security numbers. States must provide this information within 180 days of enactment for historical data and annually thereafter, with funds withheld if they fail to comply. The Secretary of Agriculture will compile and publish annual reports to Congress based on the submitted data.
This bill directs the U.S. Trade Representative to investigate whether Canada's Online Streaming Act unfairly targets American streaming companies by imposing discriminatory taxes and content requirements. It authorizes the Trade Representative to consult with affected U.S. businesses and trade partners, then potentially take retaliatory trade actions if Canada does not amend the measures. The legislation also requires regular reporting to Congress on Canada's implementation of these policies and extends similar investigative powers to other countries with comparable digital trade restrictions.
The ISLET Act amends federal regulations to allow the use of human cadaveric islets for transplantation without classifying them as drugs or biological products. This change directly affects patients with diabetes who may receive islet cell transplants and the healthcare providers who administer these procedures. The bill requires the Secretary of Health and Human Services to update existing regulations within one year and submit a progress report to Congress within six months. By removing islets from drug and biological product categories, the legislation aims to streamline regulatory oversight for this specific type of medical treatment.
This bill establishes the SECURE Health Act to strengthen the global health workforce by creating a coordinated federal strategy to train, support, and protect frontline health workers worldwide. It requires the President to develop a five-year Global Health Workforce Strategy, appoint a dedicated coordinator within the State Department, and form an interagency task force to align health investments across federal agencies. The legislation mandates detailed annual reporting on funding for health worker salaries, training, and protection measures, while also calling for an independent global report every two years to track progress. Additionally, the bill emphasizes integrated funding approaches that support multiple health needs rather than single-disease programs and requires host countries to contribute to salary support plans to ensure long-term sustainability.
This bill proposes to add 7-hydroxymitragynine to Schedule I of the Controlled Substances Act, classifying it as a controlled substance. The legislation specifically excludes naturally occurring 7-hydroxymitragynine found in kratom plants from this classification while including synthetic versions. This change would require federal regulation of synthetic forms of the compound but would not affect kratom products containing the substance in its natural state. The bill directly impacts pharmaceutical manufacturers and synthetic drug producers who would need to comply with new federal scheduling requirements.
This bill creates a new grant program to help schools access naloxone for opioid overdose emergencies. It directly affects public and private elementary and secondary schools by requiring them to certify they have trained staff (like nurses or designated personnel), maintain accessible naloxone supplies, and have a plan for trained staff on-site during school hours. Schools must also confirm their state provides adequate legal protection for staff who administer naloxone. The grants, funded through the Public Health Service Act, support these requirements to enable immediate emergency treatment of opioid overdoses in school settings.
S 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
The Child Care Modernization Act of 2025 amends the Child Care and Development Block Grant Act to improve access to high-quality child care for working parents. It requires states to develop plans with input from parents, providers, and employers, and to set payment rates that cover providers' full costs including staff salaries and benefits. The bill creates a new grant program to expand child care supply through facilities improvements and support for providers serving priority populations like homeless children, rural communities, and children with disabilities. It clarifies eligibility requirements, including income limits for families and definitions for "eligible child" and "eligible activity." The act aims to increase the number of low-income children in high-quality child care settings while supporting the child care workforce.
S 2287, the Palliative Care and Hospice Education and Training Act, establishes federal funding to expand training for health professionals in palliative and hospice care. The bill creates multiple programs including grants for education programs, fellowships for faculty to gain specialized training, and career incentive awards for students pursuing palliative care specialties. It prioritizes training in rural and underserved areas, for pediatric populations, and for racial and ethnic minorities. The bill authorizes $15 million annually through 2030 to build a more skilled palliative care workforce for patients with serious or life-threatening illnesses.
This bill, the Conscience Protection Act of 2025, strengthens protections for healthcare providers and organizations that refuse to participate in certain medical procedures (including abortion, assisted suicide, and sterilization) based on religious, moral, or ethical beliefs. It creates a private right of action allowing affected entities to seek legal remedies when their conscience rights are violated, addressing a gap in current law where victims could not defend their rights in court. The bill amends the Public Health Service Act to prohibit discrimination against such healthcare entities and establishes clearer enforcement mechanisms through the Department of Health and Human Services, including administrative investigations and civil actions. It directly affects healthcare providers, hospitals, insurers, and other health-related organizations operating under federal funding. The bill aims to address inconsistent enforcement of existing conscience protections like the Weldon Amendment, which has been challenged in cases such as California's abortion coverage mandate.
